EndoSense - Development and Evaluation of a Biofeedback Intervention to Improve Quality of Life in Endometriosis

Internally funded project


Start date : 01.10.2024


Project details

Short description

Endometriosis is a chronic condition where tissue similar to the lining of the uterus grows outside the uterus. It affects about 10% of people with a uterus. The disease can cause severe pain, especially during menstruation, sexual intercourse, or chronic pelvic pain, significantly impacting quality of life. Research suggests that persistent tension in the pelvic floor muscles may contribute to chronic pain in endometriosis. The goal of our project is to explore whether a specifically designed sEMG-biofeedback training can be used to reduce muscle tension in people with endometriosis and thereby relieve pain and improve quality of life.

Scientific Abstract

Surface electromyography (sEMG) biofeedback is a well-established, non-invasive method that enables individuals to perceive and consciously regulate physiological activity—such as pelvic floor muscle tension—in real time. In endometriosis, sEMG biofeedback may help reduce chronically elevated pelvic floor muscle tension and enhance individuals’ sense of control and self-efficacy.

The EndoSense project pursues three core objectives:
(1) To systematically assess pelvic floor muscle tension and physiological stress reactivity in individuals with endometriosis compared to healthy controls.
(2) To evaluate the acceptance and feasibility of a single-session biofeedback intervention using vaginal sEMG sensors in a laboratory setting.
(3) To qualitatively explore user needs and potential barriers to a home-based sEMG biofeedback training, which is intended to be further evaluated in a subsequent randomized controlled trial.

Involved:

Contributing FAU Organisations:

Research Areas